Research on new and better ways to treat cancer. Covers radiotherapy, targeted microdroplets, nerve-injury protection, drug combinations, and tumor models.
Most victims of stray bullets are women and individuals outside the typical high-risk age range, highlighting the need for preventive measures. The study found that most victims were unaware of the events leading to the gunfire and often died immediately or shortly after being shot.
A study by Arizona State University researchers aims to understand the connection between gut microbiota and obesity treatment outcomes. The research focuses on two popular obesity treatments: gastric bypass surgery, which has been shown to alter gut microbial populations.
A randomized trial found that standard triple therapy was more effective than newer four-drug regimens in Latin America, justifying population-wide eradication trials to prevent gastric cancers. However, comment authors disagree, citing potential risks and complications associated with mass eradication programmes.
Despite genomics' promise in treating cancer and cardiovascular disease, personalized medicine's complexities limit tailored interventions. The authors advocate for a more holistic approach focusing on the person as a whole, rather than abstract scientific manipulations.
Researchers at St. Jude Children's Research Hospital identified Tsc1 as a key regulator of the immune system, maintaining a balanced immune response by inhibiting effector T cells and naïve T cells. Loss of Tsc1 leads to premature activation and depletion of immune cells, compromising bacterial infection resistance.
A Phase III trial found that amrubicin significantly improved tumor shrinkage, symptom control, and progression-free survival compared to topotecan in lung cancer patients. Patients treated with amrubicin also reported better quality of life and fewer adverse events.
Researchers found that one-to-one therapy sessions to teach pelvic floor exercises were no more effective in managing urinary incontinence after prostate surgery than standard care. In fact, the intervention resulted in higher costs per patient without a significant impact on quality of life.
Researchers at John Theurer Cancer Center found that patients with more partner support experience less distress after stem cell transplants. The study suggests that social support plays a crucial role in improving patient outcomes and quality of life.
A new psychotherapy intervention, dignity therapy, significantly improves quality of life and enhances the dignity of patients at the end of life, while helping their families. The study found that dignity therapy reduces distress and enriches the end-of-life experience compared to standard palliative care and client-centred care.
Inhibiting heat shock transcription factor 1 (HSF1) prevents liver cancer in mice by reducing access to glucose and lipids, which are critical for tumor growth. This finding supports the idea that altering metabolism can be an effective cancer treatment.
A new study reveals that ALK rearrangement affects nearly 10% of lung cancer patients, while MET amplification occurs in another 4.1%. This could lead to targeted therapy options like crizotinib for these patients.
Researchers mapped out the order of DNA changes in advanced skin and ovarian tumors using a statistical approach, finding that key gene TP53 mutations occurred earlier than previously believed. This discovery could help identify personalized therapies for cancer patients by targeting early mutations.
A recent Nevada study found that over two-thirds of respondents approved using therapeutic cloning and stem cells to cure cancer or treat heart attacks. For treatment of less-serious conditions, approval rates were lower but still significant. The study suggests a strong public support for stem cell research in the US.
New tools and methods enable targeted gene delivery to cells in the central nervous system, offering hope for new treatments. Novel strategies include using stem cells and siRNAs to silence genes involved in neurological diseases.
Researchers at Buck Institute discover lithium profoundly prevents brain damage associated with Parkinson's disease in a mouse model. The study's findings suggest that lithium could be an effective treatment for PD patients at subclinical levels, avoiding side effects.
A holistic approach to treating cancer pain that addresses psychological, social, and spiritual needs can enhance treatment outcomes and ease suffering. Research suggests integrating palliative care from diagnosis can improve quality of life, reduce depression, and increase survival time for lung cancer patients.
The UH Cancer Center has received a significant gift to accelerate mesothelioma research, with scientists working on developing new therapies to prevent and treat the disease. Recent breakthroughs have shed light on potential causes, including exposure to erionite particles found in airborne asbestos.
A study published in Archives of Surgery found that most hospitals follow established practice guidelines for surgical treatment of cancer patients with Medicare. However, disparities in care exist, with patients receiving the right care at the right time not always guaranteed.
A multicenter pilot study found etanercept successfully weaned patients from steroid therapy, with no significant increase in adverse event rates. Larger studies are needed to investigate the safety and efficacy of etanercept for dermatomyositis treatment.
Van Andel Research Institute scientists found a protein that predicts the spread of nasopharyngeal carcinoma, a deadly head and neck cancer common in southern China and Southeast Asia. Higher levels of serglycin correlate with poor prognosis and increased metastasis, suggesting it as a therapeutic target to stop disease progression.
A low-carbohydrate, high-protein diet has been shown to slow the growth of tumors and reduce the risk of cancer in mice. The study found that restricting carbohydrate intake can limit blood glucose and insulin, promoting tumor growth. A low-carb diet also boosted the immune system's ability to kill cancer cells and prevented obesity.
Researchers used time-lapse video microscopic technology to observe early stages of ovarian cancer metastasis. The study identified the force-dependent processes necessary for tumor cells to attach to and proliferate on organs in the peritoneum.
Proactive telephone counseling helps increase long-term smoking cessation, with a positive effect on both point prevalence and prolonged abstinence. The study suggests that active recruitment methods do not significantly impact quit rates, contrary to previous assumptions.
Researchers at University of Western Ontario discovered how biochemical pathways can be rewired in cancer cells to resist apoptosis, a key process in normal cell turnover. This 'rewiring' allows cancer cells to ignore death signals and potentially evade therapy.
A clinical trial at Michigan State University is testing the effectiveness of acetazolamide in reducing vision loss in patients with idiopathic intracranial hypertension (IIH). The study aims to establish evidence-based treatment strategies and follow patients for up to four years to observe long-term treatment outcomes.
A recent study by Fred Hutchinson Cancer Center found that bankruptcy rates among cancer patients rise fourfold within five years of diagnosis. The risk is highest for lung, thyroid and leukemia/lymphoma cancer patients, who face significant financial stress due to income loss and treatment costs.
Researchers identified phytochemicals in mushrooms that block aromatase enzyme activity, potentially reducing estrogen levels and killing hormone-dependent breast cancers. Early-stage studies show promise in preventing breast cancer recurrence and treating lung cancer.
A new study by St. Michael's Hospital reveals that female prisoners who did not participate in a drug treatment program after their release were 10 times more likely to return to prison within one year. The study highlights the importance of post-release treatment programs for prisoners with substance abuse problems.
A recent Korean survey found that most cancer patients, family members, oncologists, and the general public are receptive to ending futile life-sustaining treatments for terminally ill patients. This positive attitude towards withdrawing such treatments is attributed to patient autonomy and hastening the dying process.
Advancements in telemedicine, medical robots, biomarkers, neural engineering, tissue engineering, and regenerative medicine are transforming patient care. Five key areas of convergence will drive healthcare's future.
A study of 1032 patients with early RA found that initial treatment with adalimumab plus methotrexate provided high levels of disease control, with 44% achieving sustained low disease activity. Patients who continued treatment maintained good clinical and radiographic responses, even after withdrawing treatment.
A recent study found that men who walk briskly after diagnosis have a 57% lower rate of progression of disease than those who walk at an easy pace. Brisk walking can delay or even prevent progression of prostate cancer.
Research suggests that doctors should tailor treatment to specific qualities of second tumor, regardless of whether it's old or new. Studies found that 89% of recurring tumors differed in at least one characteristic compared to the original tumor.
Researchers have discovered a new mechanism of action for Herceptin, revealing its ability to stimulate interferons and activate lymphocytes. Combining Herceptin with lymphocyte-stimulating therapies greatly increases efficacy in animals, paving the way for targeted therapies.
A study published in Archives of Otolaryngology–Head and Neck Surgery found that propranolol therapy improved the size and quality of head and neck hemangiomas in children. The medication was effective in reducing tumor size, flattening lesions, and changing their color, even in cases where previous treatments were unsuccessful.
A new study from UCSD School of Medicine reveals the plasticity of some gene expression programs, allowing for alternative induced gene expression. This plasticity may contribute to cancer cell growth and normal differentiation, with implications for hormone therapy.
A new study examines the trend of radical nephrectomy rates in patients with clinically localized renal masses and finds that despite guidelines recommending kidney preservation, laparoscopic procedures have become more prevalent than expected. This shift may lead to increased morbidity and mortality due to chronic renal insufficiency.
Researchers from Fox Chase Cancer Center investigated the effectiveness of active surveillance in patients with small renal masses. They found that in select patients, active surveillance may be a viable option when surgery is risky due to poor health or advanced age.
Patients with small kidney tumors are more likely to be offered partial nephrectomy based on surgeon's case volume and type of practice. Fellowship-trained surgeons in academic centers were 70-80% more likely to follow guidelines, while those in private practice saw fewer patients offered radical nephrectomy.
Researchers from NewYork-Presbyterian/Weill Cornell presented studies on the effectiveness of robotic-assisted laparoscopic radical prostatectomy, finding lower perioperative morbidity and improved oncologic outcomes compared to open and laparoscopic approaches. Additionally, they investigated the feasibility and safety of robot-assist...
The healthcare system will double the size of its cancer treatment facility in a new hospital, allowing more patients to receive care from more physicians. The remaining funds will support critical cancer research, bridging the gap between lab discoveries and patient therapies.
Researchers found that a small RNA pathway is required to establish DNA methylation, a process that silences genes. This discovery may lead to new therapies for cancer and other diseases by reactivating silenced tumor-suppressor genes.
A new study by the NYU Cancer Institute reveals that novel mutations in the Notch signaling pathway lead to the development of chronic myelomonocytic leukemia, a type of blood cancer. The study suggests potential targets for future therapies.
A new study published in Music and Medicine found that palliative care patients experience enhanced pain relief, comfort, relaxation, and mood through a unique music therapy project. The project, led by Concordia University's Sandi Curtis, combined students with professional musicians to provide individualized music therapy sessions.
A study found that CTPA screening led to a 81% increase in PE diagnoses, but only a 3% decrease in mortality rates. The authors suggest overdiagnosis due to the detection of clinically insignificant small emboli.
A study from Beth Israel Deaconess Medical Center found that nearly 3% of Americans using mind-body therapies were referred by a healthcare provider, suggesting a shift towards mainstream acceptance. These patients were sicker and used the healthcare system more than those who self-referenced for MBT.
A new UK-wide centre of excellence will train PhD researchers to use next-generation laser-operated accelerator devices for improved cancer treatment and enhanced homeland security. The programme combines physics with biology and medicine, offering students opportunities to work with industry and health authorities.
Researchers identified a regulatory protein that inhibits cancer cell spread by removing an invasive enzyme. This enzyme degrades surrounding tissues, facilitating cancer metastasis. The discovery may lead to more targeted therapies with specific inhibitory functions.
A new study found that radiologists using MRI can correctly identify the primary site of cancer in 79% of cases, even when biopsy results are inconclusive. This improves patient outcomes by providing more accurate treatment options.
The landmark event brought together pediatric urologists worldwide to share ideas and advance research. Key findings highlight the growing importance of pediatric urology as a global specialty.
A study of 435 women who underwent treatment for precancerous cervical lesions found that a three-cytological-smears post-treatment surveillance strategy is effective in identifying women at long-term risk of cervical cancer. By adding high-risk human papillomavirus (hrHPV) testing, the need for subsequent screens can be reduced.
A healthcare alliance has launched a training program in Mexico to address the significant rates of tobacco usage in Latin America. The program aims to enhance access to proven treatment methods and promote effective tobacco control policies across the region.
Global Bridges, a healthcare alliance for tobacco dependence treatment, is launching training in the Eastern Mediterranean Region. The first training will engage 15 health care professionals from Jordan and focus on culturally appropriate tobacco dependence treatment.
Scripps Research and Moffitt Cancer Center collaborate on a $2.1 million grant to understand the origins of prostate cancer and develop novel treatments. The study aims to define how B cells control the spread of hormone-refractory cancer, potentially leading to effective treatments.
Multipolar electrocoagulation ablation therapy in combination with acid suppression is a safe and effective method to ablate nondysplastic Barrett's esophagus over the long term, according to a new study. No adenocarcinoma or high-grade dysplasia developed in any of the study patients.
Researchers found three distinct gut types, each associated with unique microbial genetic markers. These markers may help diagnose diseases like colo-rectal cancer and predict treatment outcomes.
University of Cincinnati researchers have successfully produced large RNA nanoparticles using a bipartite approach, overcoming challenges in industry-scale production. The nanoparticles, containing small interfering RNA, show a half-life of between five and 10 hours in animal models, are non-toxic and produce no immune response.
University of Iowa researchers identify TRAF6 as essential for LMP1 functions, which can be targeted to develop new therapies for B cell lymphomas and autoimmune diseases. The discovery may lead to the development of novel treatments that mimic CD40 activation while avoiding disruptions in normal immune function.
A phase 3 trial found subcutaneous administration of bortezomib to be as effective as intravenous delivery, but with a better safety profile and lower rates of peripheral neuropathy. Subcutaneous injection could provide an easy home-based treatment option at reduced cost.
A group of radiologists and biochemists have developed a new approach to improve the accuracy and reliability of medical imaging. By creating standardized benchmarks and calibration objects, they aim to provide hard numbers that can be used to justify treatments and accelerate cancer treatment approvals.